This study investigated the mechanisms of hydroquinone toxicity and assessed the relationships between its cytotoxic, genotoxic, and cytogenetic effects tested at 8, 140, and 280 µg mL -1 in human peripheral blood lymphocytes exposed for 24 h. The outcomes of the treatments were evaluated using the apoptosis/necrosis assay, the alkaline comet assay, and the cytokinesis-block micronucleus (CBMN) cytome assay. The tested hydroquinone concentrations produced relatively weak cytotoxicity in resting lymphocytes, which mostly died via apoptosis. Hydroquinone's marked genotoxic effects were detected using the alkaline comet assay. Significantly decreased values of all comet parameters compared to controls indicated specific mechanisms of hydroquinone-DNA interactions. Our results suggest that the two higher hydroquinone concentrations possibly led to cross-linking and adduct formation. Increased levels of DNA breakage measured following exposure to the lowest concentration suggested mechanisms related to oxidative stress and inhibition of topoisomerase II. At 8 µg mL -1 , hydroquinone did not significantly affect MN formation. At 140 and 280 µg mL -1 , it completely blocked lymphocyte division. The two latter concentrations also led to erythrocyte stabilization and prevented their lysis. At least two facts contribute to this study's relevance: (I) this is the first study that quantifies the degree of reduction in total comet area measured in lymphocyte DNA after hydroquinone treatment, (II) it is also the first one on a lymphocyte model that adopted the "cytome" protocol in an MN assay and found that lymphocytes exposure even to low hydroquinone concentration resulted in a significant increase of nuclear bud frequency. Considering the limitations of the lymphocyte model, which does not possess intrinsic metabolic activation, in order to unequivocally prove the obtained results further studies using other appropriate cell lines are advised.
toxic concentrations of hydroquinone during 24, 41, and 48 hours showed no damage on chromosome structure (9) .
The mechanisms that drive the biological effects of hydroquinone, especially at cellular level, have not yet been fully explained. The contradictory results obtained thus far using well-established cytogenetic methods call for further studies, which motivated us to perform this investigation. Its aim was to explore the mechanisms of hydroquinone toxicity and assess the relationships between its cytotoxic, genotoxic, and cytogenetic effects tested at 8, 140, and 280 µg mL -1 in human peripheral blood lymphocytes exposed for 24 h. This experimental model was chosen since lymphocytes are primary cells with a stable genome, commonly used for genotoxicity testing in many contemporary studies (13) (14) (15) (16) (17) . The outcomes of treatment were evaluated using the apoptosis/necrosis assay, the alkaline comet assay, and the cytokinesis-block micronucleus (CBMN) cytome assay. All of these methods are wellestablished in genetic toxicology and have proven useful in studies with different plant extracts or their active constituents (18) (19) (20) (21) (22) (23) (24) (25) (26) .
Considering that the results of other similar reports regarding hydroquinone toxicity were controversial and difficult to confirm unambiguously, our intention was to re-assess and verify previous observations using a similar study design but with certain changes in the methods applied.
MATERIALS AND METHODS

Chemicals and reagents
Hydroquinone (1,4-dihydroxybenzene; CAS Number: 123-31-9) was purchased from Sigma-Aldrich (Steinheim, Germany). If not specified, other chemicals and reagents were obtained from the same supplier.
Blood sampling
A peripheral blood sample was collected from a healthy male non-smoker (aged 41 years) who was not exposed to any known genotoxic agents and did not undergo any diagnostic or therapeutic irradiations for one year before the study. Written informed consent was obtained from the blood donor. This experiment was part of a research conducted within the preparation of a PhD thesis of one of the co-authors, and has been approved by the Faculty of Science, University of Zagreb Ethics Committee.
A total of 20 mL of blood was collected by venepuncture under sterile conditions into blood collection tubes (BD vacutainer, Becton Dickinson, Franklin Lakes, NJ, USA) which contained lithium heparin as an anticoagulant. One portion of blood was immediately used for the lymphocyte isolation, while the other one was used for the CBMN cytome assay.
Isolation of lymphocytes
Lymphocyte isolation was performed using Histopaque ® 1077 reagent (Sigma-Aldrich, St. Loius, MO, USA) according to the manufacturer's instructions (27) . Whole blood was mixed with an equal volume of cell culture medium (Gibco ® RPMI 1640 (1X) medium, Life Technologies, Paisley, UK). Aliquots of diluted blood were carefully layered onto Histopaque ® 1077 and immediately centrifuged at 400×g for 30 minutes (Hettich Rotofix 32 centrifuge, Tuttlingen, Germany). Then the layer containing lymphocytes was carefully aspirated and transferred into a centrifuge tube filled with the cell culture medium. This solution was gently mixed and centrifuged at 250×g for 10 min. The same procedure was repeated once more. The obtained lymphocyte pellet was resuspended with the cell culture medium using a Pasteur pipette. Lymphocyte viability was checked using trypan blue staining and was over 96 %. There were 2.5×10 5 cells per mL of the suspension. The isolated lymphocytes were then used in the experiments.
Experimental design Selection of the tested concentrations
The tested concentrations were selected adhering to the available literature (4, (28) (29) (30) (31) (32) (33) (34) (35) (36) . The lowest tested concentration of 8 µg mL -1 was calculated by taking into account (I) the maximum allowable daily intake of bearberry leaf extract standardized on arbutin (i.e., 800 mg), (II) the average human body weight of 70 kg, and (III) the fact that 70 % of arbutin is metabolised into hydroquinone (4) . Under normal conditions, hydroquinone produced from arbutin is rapidly detoxified. However, we wanted to assess how severe effects could be produced if this entire amount remained available and freely entered into cells. Two higher concentrations of 140 and 280 µg mL -1 were calculated based on former reports regarding the safety of bearberry leaf preparations (35, 36) which did not find significant cytogenetic effects or increased micronuclei induction in vitro, as well as based on previous related studies (32, 33) , which tested hydroquinone at millimolar concentrations on a lymphocyte model using the MN-and comet assay, respectively.
Lymphocyte treatments
Aliquots of the lymphocyte suspension (V = 1 mL per each replica) were placed in sterile Falcon ® tubes (Fisher Scientific, Pittsburgh, PA, USA) and mixed with the tested compound at 8, 140 and 280 µg mL -1 . Non-treated lymphocytes represented negative control. To prepare a positive control sample, lymphocyte suspension was mixed with 1.25 µg mL -1 of bleomycin (Nippon Kayaku Co. Ltd., Tokyo, Japan). All of the samples were incubated for 24 h at 37 °C in 5 % CO 2 humidified incubator (Heraeus Hera Cell 240 incubator, Langenselbold, Germany). For each experimental group, duplicate samples were set up. Following treatment, lymphocyte viability was immediately checked (using a double staining procedure with acridine orange and ethidium bromide), and agarose microgels for the alkaline comet assay were prepared.
For the CBMN cytome assay, whole blood was treated for 24 h at 37 °C with selected hydroquinone concentrations or bleomycin (1.25 µg mL -1 ) for positive control, according to recommendations for in vitro treatments (37) . Afterwards the cell cultures were established and grown for the next 72 h. Then microscopic slides were prepared and subjected to light-microscopic analyses to study cytogenetic outcomes and lymphocyte proliferation.
Fluorescent viability assay with ethidium bromide and acridine orange (EtBr/AO) staining
As proposed by Duke and Cohen (38) , lymphocytes were stained with a mixture of fluorescent dyes [100 µg mL -1 EtBr and 100 µg mL -1 AO dissolved in PBS (1:1 v/v)], and immediately analysed under an epifluorescence microscope (Olympus BX51, Tokyo, Japan; 400× magnification). Three independent scorings were performed and a total of 300 lymphocytes per sample per experiment were morphologically evaluated to determine the percentages of viable, apoptotic, and necrotic cells. Viable cells fluoresced brightly green due to the intercalation of AO in their DNA. Dead cells had a dark orange/red stained nucleus due to the binding of EtBr in their DNA. In the early phase of apoptosis, green stained fragmented nuclei were visible, while late apoptosis was characterized by an orange staining of the cytoplasm.
Alkaline comet assay
The alkaline comet assay was performed according to standard procedure (39) , with minor adjustments. To prepare agarose microgels, we used fully frosted precleaned microscope slides (Surgipath ® , Cambridgeshire, UK) precoated with 0.6 % normal melting point (NMP) agarose. Over this agarose layer we gently pipetted a second layer that was composed of 5 µL of the lymphocyte suspension mixed with 0.5 % low melting point (LMP) agarose. The top layer was comprised of 0.5 % LMP agarose. These microgels were subjected to overnight lysis at 4 °C in a freshly mixed buffer [2.5 mol L -1 NaCl (Kemika, Zagreb, Croatia), 100 mmol L -1 Na 2 EDTA, 10 mmol L -1 Tris-HCl, 1 % Na-laurilsarcosinate, pH=10] with 1 % Triton X-100 and 10 % dimethyl sulfoxide (Kemika, Zagreb, Croatia). Alkaline denaturation lasted for 20 min in a freshly prepared buffer (300 mmol L -1 NaOH, 1 mmol L -1 Na 2 EDTA, pH=13.0). After denaturation, the microgels were arranged in a horizontal electrophoresis unit filled with the same buffer and subjected to 20 min of electrophoresis (at 4 °C, 25 V, and 300 mA). Using three changes of 0.4 mol L -1 Tris-HCl buffer (pH=7.5), the microgels were neutralized and washed. Before microscopic analysis, they were stained for 10 minutes with 100 µL of EtBr, applied at 20 µg mL -1 . One well-trained scorer performed all of the comet measurements on the coded/blinded slides under an epifluorescence microscope (Olympus BX51, Tokyo, Japan; at 200× magnification), using a computer-based image analysis system with Comet Assay IV TM software (Perceptive Instruments Ltd., UK). A total of 200 randomly selected comets per each tested concentration (or control) were measured on replicate slides in two independent evaluations. As indicators of DNA damage, tail length (presented in micrometres), tail intensity (i.e., DNA% in tail), and total area (it represents the overall surface area of the comet) were chosen.
Cytokinesis-block micronucleus (CBMN) cytome assay
We applied a standard protocol for the MN assay as recommended by Fenech and Morley (40 th hour, the cytokinesis blocking agent cytochalasine B (Sigma-Aldrich, St. Louis, MO, USA) was added (6 µg mL -1 ). After 72 h of in vitro growth, cultures were harvested by standard procedures including incubation in hypotonic potassium chloride (Kemika, Zagreb, Croatia) solution, and several repetitions of fixation and centrifugation (Hettich Rotofix 32 centrifuge, Tuttlingen, Germany) to obtain lymphocyte suspension. We used an ice-cold fixative made up of 1 part acetic acid (Kemika, Zagreb, Croatia) to 3 parts methanol (Kemika, Zagreb, Croatia). Lymphocyte suspension was dropped onto clean slides. Air-dried slides were stained with 5 % Giemsa solution (Merck, Darmstadt, Germany) for 10 minutes at room temperature. Microscopic analysis was carried out under a light microscope (Leitz, Wetzlar, Germany) at 1000× magnification (oil immersion).
The identification and scoring of micronuclei (MN), nuclear buds (NB), nucleoplasmic bridges (NPB), and apoptotic and necrotic cells was performed using criteria recommended by Fenech et al. (41) . A total of 2000 binucleated (BN) cells was examined for each treatment (1000 BN cells per each replica). The same slides were used to study the nuclear division index (NDI), by screening 1000 cells per sample (500 cells per slide). To calculate the NDI, we used the formula proposed by Eastmond and Tucker (42) , NDI = (M1 + 2M2 + 3M3 + 4M4)/N, where M1-M4 denote the number of cells with 1-4 nuclei, respectively, and N is the number of cells scored.
Statistical analysis
The data were analysed using Dell™ Statistica™ 13.2 software (Dell Inc., Tulsa, OK, USA). For each data set, basic descriptive statistical parameters such as mean, standard deviation, standard error, median, and minimum and maximum values were determined. To test the normality of distribution, we used Shapiro-Wilks Normality Test. The data obtained with alkaline comet assay were logarithmically transformed to normalise the distribution and equalise variances. Multiple comparisons between groups were performed using analysis of variance (ANOVA) on logtransformed data with the Scheffe's post-hoc test.
Comparisons between values obtained for lymphocyte viability, CBMN assay, and lymphocyte proliferation were conducted using Pearson's χ 2 -test. The level of statistical significance was set at p<0.05.
RESULTS
Lymphocyte viability
The results obtained using dual ethidium bromide/ acridine orange staining showed a concentration-dependent cytotoxicity in all of the hydroquinone-treated samples. At the two higher concentrations lymphocyte viability was significantly lower than in negative control (Table 1) .
However, as the highest tested concentration caused only 13 % of dead cells, one could emphasize that at the applied in vitro settings hydroquinone had low cytotoxic potential. Majority of cells died via apoptosis, which dominated over necrosis at the two higher hydroquinone concentrations. Treatment with the lowest hydroquinone concentration caused the same proportion of apoptotic and necrotic cells.
Primary DNA damage in peripheral blood lymphocytes estimated by the alkaline comet assay
Results regarding primary DNA damage levels in peripheral blood lymphocytes measured by the alkaline comet assay, and detailed explanations of their statistical significance are shown in Table 2 . Control lymphocytes had low levels of spontaneous primary DNA damage. Twentyfour-hour treatment with all of the three hydroquinone concentrations caused statistically significant deviations in almost all of the comet parameters evaluated. As we expected, the highest values for all of the comet parameters were measured in the positive control sample, which is in agreement with the mechanism of hydrogen peroxide action to DNA.
The most prominent change observed after 24-hour treatment was a significantly decreased comet total area in all of the samples treated with hydroquinone compared to negative control. It is worth to mention that the comets measured in the sample treated with 8 µg mL -1 of hydroquinone had more than a 2-fold lower mean total area compared to those measured in the negative control. Treatment with 140 µg mL -1 lowered this value by almost 3.7-fold, while comets measured in the sample treated with 280 µg mL -1 of hydroquinone had a 4.3-fold lower mean total area compared to those measured in the negative control. To further document this observation, we calculated the average reduction of the total comet area after hydroquinone treatments with respect to the control cells and these results are shown in Figure 1 .
The appearances of lymphocyte nucleoids treated with hydroquinone observed under fluorescence microscope after staining with ethidium bromide are displayed in Figure 2 . It should be noted that DNA in the hydroquinone-treated samples was more condensed than the DNA in the negative control.
Cytokinesis-block micronucleus cytome assay
At two higher concentrations tested, hydroquinone impaired the in vitro growth of short-term lymphocyte cultures, which made it impossible to accomplish the testing and obtain valuable slides for the microscopic analysis in the CBMN cytome assay. As shown in Figure 3 , despite repeated centrifugation and rinsing of the cell pellets, it was not possible to obtain lymphocyte suspensions. Microscopic analysis of the obtained cell suspensions showed the presence of a large number of erythrocytes that were not lysed during the sample processing, and almost no lymphocytes. Such a result suggests a specific mechanism of hydroquinone action on erythrocyte membranes, which will be discussed later on.
Results of the CBMN cytome assay suggest a low potential of hydroquinone to induce micronuclei at 8 µg mL -1 (Table 3) . However, at the same concentration hydroquinone showed significant potential towards the formation of nuclear buds (NBs). One of the most typical examples of NB appearance visible under the light microscope is shown in Figure 4a . There were no statistically significant increases in the number of apoptotic and necrotic cells with respect to negative control. As anticipated, positive control (bleomycin) had the highest value for all parameters of the CBMN cytome assay, which confirms the sensitivity and specificity of the method used (Table 3) .
Lymphocyte proliferation analysis
Results regarding lymphocyte proliferation in cell cultures treated in vitro with 8.0 µg mL -1 of hydroquinone and in the corresponding negative and positive controls are reported in Table 4 . At the concentration tested, hydroquinone Jurica K et al. In vitro assessment of the cytotoxic, DNA damaging, and cytogenetic effects of hydroquinone in human lymphocytes Arh Hig Rada Toksikol 2017;68:322-335 impaired lymphocyte proliferation and significantly lowered the nuclear division index (NDI) value compared to negative control. The most prominent was a delay of the lymphocyte cell cycle in M2, which resulted in a significantly lower proportion of M3 cells, as well as a complete absence of M4 cells.
Figure 1 Average reduction of the total comet area observed after 24 h in vitro treatment of peripheral blood lymphocytes with hydroquinone applied at three concentrations (percentage of reduction was calculated with respect to the mean total comet area measured in the negative control cells)
DISCUSSION
Although hydroquinone toxicity has been studied in various experimental models thus far, which distinguishes ours from other previously conducted studies with human lymphocytes is its comprehensive design, which coupled cell viability assessment with the alkaline comet assay and CBMN cytome assay to establish the relationship between the cytotoxic, genotoxic, and cytogenetic effects of the tested compound. Here we will briefly list the added value of our findings. (I) This study is the first to quantify the degree of reduction in the total comet area measured in lymphocyte DNA after hydroquinone treatment, a parameter which the foregoing comet assay studies did not take into account when explaining the mechanisms behind the infliction of primary DNA damage caused by this compound. Based on our observations, the evaluation of this particular comet parameter (which points both to the changes in the overall surface area of the comet and to the impairments in the denaturation step) can be suggested in those cases where chemicals with hydroquinone-related mechanisms of action at DNA level are studied using the conventional alkaline comet assay procedure. (II) None of the studies conducted so far with the lymphocyte MN assay adopted a "cytome" protocol, to simultaneously evaluate the incidence of other cytogenetic changes, such as nuclear buds and nucleoplasmic bridges, apart from micronuclei. The present study was the first one which reports the results of a CBMN cytome assay and found that exposure of lymphocytes to even low hydroquinone concentration results in a significant increase of nuclear bud frequency. Aside from what this study added to the existing knowledge on the subject, it also confirmed observations by other authors regarding MN induction, disturbed lymphocyte cell cycle, toxic effects of hydroquinone, and the mechanisms behind its genotoxicity at cell level. The practical significance of each result will be discussed below in more detail.
When all of the obtained results are taken into account, we can say that two of hydroquinone's effects raised the most concern: (I) a significant amount of specific primary DNA damage as suggested by the values of alkaline comet assay parameters at all of the tested concentrations, and (II) a significant impairment of lymphocyte growth in vitro, especially at the two higher concentrations. We believe these findings are particularly important from the toxicological point of view because of the fact that human exposure to hydroquinone in some cases can be relatively high. Besides occupational exposure, which is limited to specific work settings (e.g., production of hydroquinone, photographic developers, rubber, and other products that contain hydroquinone), there are many sources of Jurica hydroquinone in otherwise "unexposed" people, which include smoking, consumption of different foods and beverages, use of various herbal preparations and over-thecounter medicines (for instance paracetamol or acetaminophen), as well as the catabolism of proteins (especially the amino acid tyrosine) and other substrates by microorganisms in the digestive system (2, 8, 43 ). An example of a food item very rich in free hydroquinone is pear, with 0.02-0.05 µg g -1 (8) . A threat also arises not only from excessive intake of free hydroquinone, but also from excessive consumption of various items containing its glycoside arbutin. Some herbal preparations like bearberry and strawberry tree leaf extracts also contain significant amounts of arbutin (4, 44) . Furthermore, an additional route of exposure to arbutin is the dermal one, via application of cosmetics preparations, especially creams used for skin whitening (45) (46) (47) . The use of arbutin preparations has steadily increased after hydroquinone administration for the same purposes was banned by 24 th Directive 2000/6/ EC of the European Parliament (48) .
Acute exposure is not associated with significant human health risk, considering that hydroquinone undergoes rapid metabolism to glucuronide and sulphate ester conjugates (2) and has no potential for accumulation in an organism. The amount of free hydroquinone in tissues and organs is less than 2 % of the total arbutin/hydroquinone dose administered (8) . However, repeated exposure is a matter of concern and this is why the use of herbal preparations like bearberry leaf extract should be limited to short periods of time (4) .
Most studies with hydroquinone conducted so far, including ours, tested the effects of quite high hydroquinone concentrations, considering that the maximum exposure level to free hydroquinone after ingestion of a therapeutic daily dose of bearberry leaf preparation (containing 420 mg of arbutin) is estimated to be 11 µg kg -1 b.w. day -1 (8) . Roughly, if we convert kg to L, this dose corresponds to a concentration of 0.011 µg mL -1 . Interestingly, by testing much higher hydroquinone concentrations, we observed a relatively weak cytotoxicity in lymphocytes. This was not a surprise, considering that lymphocytes are "stuck" in the G 0 phase of the cell cycle, characterized by the slowing down of many intracellular processes (49, 50) . The majority of dead cells we detected Jurica K et al. In vitro assessment of the cytotoxic, DNA damaging, and cytogenetic effects of hydroquinone in human lymphocytes Arh Hig Rada Toksikol 2017;68:322-335 using EtBr/AO staining died via apoptosis. We assume that cells which possibly contained highly damaged DNA following treatment initiated mechanisms of controlled self-killing. However, due to methodological constrains, we were not able to deduce which exact mechanisms were responsible for hydroquinone-induced apoptosis in our experiment since the double fluorescence staining assay used in the present study permits only the morphological discrimination of dead cells. Therefore, we cannot propose the precise mechanisms behind apoptosis, and if the same experiment is repeated or expanded in the future, this has to be explained using more sophisticated methods for apoptosis detection/characterization. However, the mechanisms underlying hydroquinone cytotoxicity have been explored in several studies on other model systems. Hiraku and Kawanishi (51) observed that apoptosis in hydroquinone-and benzoquinone-treated HL-60 cells was potentiated by internucleosomal DNA fragmentation caused mostly by oxidative DNA damage. Inayat-Hussain et al. (52) found that hydroquinone caused apoptosis by different mechanisms of HL-60 promyelocytic leukaemia cells (via caspase-independent pathways) and in myeloperoxidasedeficient Jurkat T-lymphoblastic leukaemia cells (via caspase activation). Terasaka et al. (53) found that treatment of HL-60 cells with hydroquinone caused the release of cytochrome c and activation of procaspase-3 and -9, suggesting that hydroquinone activates the intrinsic pathway of apoptosis. Yang et al. (54) found that hydroquinone strongly induces apoptosis in neutrophils and eosinophils through the caspase 9/3-dependent pathway and the increased production of reactive oxygen species. Lee at al. (55) reported that the same caspase 9/3 pathway was responsible for hydroquinone-induced human lymphocyte apoptosis.
Despite the relatively low cytotoxicity in resting lymphocytes, this study found marked genotoxic effects of hydroquinone. To estimate the levels of primary DNA damage in hydroquinone-treated lymphocytes, we used an alkaline version of the comet assay, which detects the widest range of lesions (56) (57) (58) . First literature reports regarding hydroquinone effects detected by the comet assay in peripheral blood lymphocytes treated in vitro originated from Andreoli et al. (59) who found that hydroquinone, along with two other benzene metabolites -benzoquinone and benzenetriol -exerted a significant genotoxic effect on resting lymphocytes, with the lowest effective concentrations below 1 µg mL -1 . Our genotoxicity assessment in lymphocyte model was focused on three comet parameters: tail length, tail intensity, and total area, all of which were simultaneously measured by the Comet Assay IV TM software. Tail length and tail intensity are the two most frequently used comet parameters, often studied concomitantly. Nevertheless, tail intensity, which points to the number of DNA breaks, is considered the most suitable indicator of DNA damage (56, 57) , as in contrast to tail length, it continues to increase beyond a critical amount of damage. The reason why we selected total area as a parameter of interest was that, following extensive analysis of the obtained results, this parameter pointed to interesting discoveries regarding hydroquinone genotoxicity. This parameter has not frequently been involved in the evaluation of comet assay results, but the results reported in certain previous studies (59-63) confirm its value.
Figure 3 Preparation of lymphocyte samples for CBMN Cytome assay [At the bottom of the left tube a cell pellet, obtained by repeated fixation (with ice-cold fixative made up of 1 part acetic acid to 3 parts methanol) and centrifugation of negative control lymphocyte sample is shown (white arrow). The right tube shows the lymphocyte sample exposed for 24 h to 140 µg mL -1 of hydroquinone which was handled by the same procedure, however, it was not possible to lyse and remove erythrocytes from the cellular sediment (black arrow)]
We found that 24-h treatment with all three hydroquinone concentrations caused statistically significant deviations of almost all of the evaluated comet parameters. Their values were markedly decreased compared to control, which indicated specific mechanisms of hydroquinone-DNA interactions. Significantly lower DNA migration compared to control, and especially reduced total area of the comets we observed in hydroquinone-treated cells might indicate formation of cross-links, which in turn impaired denaturation of DNA. This assumption is highly possible, as formation of DNA-protein cross-links was previously documented in a study by Amin and Witz (64) in HL-60 cells exposed to 25-100 µmol L -1 of hydroquinone for 4 h. Similarly, Luo et al. (65) in their comet assay study in HepG2 cells observed the maximum of DNA migration at 25 µmol L -1 of hydroquinone, while exposure to 50 µmol L -1 caused a reduction in DNA migration, which they related to the formation of DNA-protein cross-links. Considering what is known about the mechanisms of action for hydroquinone, and our own findings, we propose that exposure to hydroquinone at the two higher doses led to the formation of intra-and inter-strand DNA-DNA and DNA-protein cross-links, possibly also to formation of adducts in lymphocyte DNA, which prevented normal DNA denaturation during the alkaline denaturation step, and hindered DNA migration during electrophoresis.
As another important mechanism of hydroquinone action at DNA level, the available literature suggests the inhibition of topoisomerase II enzyme (66) (67) (68) and induction of oxidative stress (33, 65) , resulting in a significant amount of DNA breaks. According to Andreoli et al. (33) , hydroquinone produces significantly more primary DNA damage in isolated human lymphocytes than in the whole blood leukocyte population. This was primarily due to the influence of the enzymes catalase and glutathione peroxidase from erythrocytes (present in whole blood samples) on reactive hydroquinone metabolites and free radicals. Furthermore, under the influence of the enzyme myeloperoxidase [which is normally present in white blood cells (69) ], hydroquinone is also converted into the more toxic reactive metabolite benzoquinone. It is known as a potent inducer of DNA adducts (70), aneugen, and potent inducer of micronuclei (29, 71) . As mentioned before, our results suggest that the two higher hydroquinone concentrations possibly led to cross-linking and adduct formation. However, it is high likely that following exposure to the lowest tested concentration, the inhibition of topoisomerase II possibly played a more important role than cross-linking. This was sustained by the significantly higher values of all comet assay parameters measured in the sample treated with 8 µg mL -1 compared to the other two hydroquinone-treated samples. Also, findings by Frantz et al. (66) suggest that 1,4-benzoquinone inhibited topoisomerase II in in vitro conditions at concentrations of ≥10 µmol L -1
. The lowest tested hydroquinone concentration in our study corresponded to 72.6 µmol L -1 , which speaks in favour of the same effects.
Considering that the alkaline comet assay cannot provide information about lymphocyte proliferation status, we extended our research to the CBMN cytome assay, one of the most comprehensive methods which enables the simultaneous study of chromosome damage, mitotic spindle apparatus damage, cell cycle kinetics, and cytotoxicity in treated cell cultures (37, 72, 73) .
Hydroquinone potency towards MN induction in human peripheral blood lymphocytes in vitro was tested in several studies so far (28) (29) (30) (31) (32) (33) (34) 74) . The reported results are rather controversial, mainly due to different exposure conditions, duration of lymphocyte cultivation, and time of hydroquinone administration. In some studies, isolated lymphocytes were treated (29, 32, 34, 74) , while other used whole blood cultures (28, 30, 31) . MN induction was observed after exposure to a wide range of hydroquinone concentrations, mainly corresponding to 1-300 µmol L As mentioned in the Results section, the present study was only able to analyse preparations obtained from a sample exposed to the lowest tested hydroquinone concentration, which corresponded to 72.6 µmol L -1 . In that sample, there was no significant deviation in MN number compared to negative control. These findings are comparable to previous reports by Migliore and Nieri (28) and Van Hummelen and Kirsch-Volders (30) , who at similar concentrations also did not record a significant increase in MN in the donors of blood used for testing.
We have to stress that none of the aforementioned studies evaluated the incidence of other types of cytogenetic damage covered by the "cytome" assay, as we have done. Therefore, our study added original and novel information regarding hydroquinone cyto/genotoxicity at cellular level. Particularly important was the finding regarding a significantly increased incidence of nuclear buds. Nuclear budding happens during the S-phase of a cell cycle, and it is likely that DNA repair processes resulted in the formation of excessive amplified DNA, which concentrated in the peripheral part of the nucleus and budded out (72) . As mentioned before, we also found increased level of primary DNA damage, which was obviously repaired during lymphocyte growth in vitro. However, since our CBMN assay focused only at one concentration, the observed phenomenon of nuclear budding following hydroquinone treatment has to be proven further by testing a much wider range of concentrations, not only in lymphocytes, but also in other cell types in order to obtain greater insight into the mechanism of their formation after exposure to the tested compound.
Among the other endpoints studied, we also evaluated how the tested compound influences lymphocyte proliferation. Judging from the values of the nuclear division index, hydroquinone at 8 µg mL -1 (or 72.6 µmol L -1 ) significantly impaired lymphocyte cell kinetics compared to control. Our observations regarding lymphocyte proliferation are consistent with previous investigations. Lippoli Doepker et al. (34) found a block in lymphocyte division at certain hydroquinone concentrations, which was demonstrated by a decrease in the percentage of binucleated cells and the value of the division index. In their study, MN scoring was limited to concentrations of 25, 50 or 75 µmol L -1 and above, depending on the blood donor. Previous studies that used whole blood in MN assay also reported mitotic delays and cytotoxicity as limiting factors to ultimately accomplish the assay, particularly at high hydroquinone concentrations. Migliore (34) also reported that hydroquinone caused more impairment in the growth of cultures of isolated lymphocytes used in the MN assay than in cultures established using whole blood. They assume that when whole blood was used, the presence of additional proteins and cell types stabilizes hydroquinone, diminishes the formation of oxidative species, and offers additional binding sites for its reactive metabolite benzoquinone. As a consequence, the levels of oxidative degradation products capable of interacting with the mitotic apparatus are reduced, which also reflects upon the cell cycle delays. Furthermore, we also have to mention that another possible reason for the failed testing using the CBMN cytome assay with the two higher hydroquinone concentrations possibly stood behind its specific effect on erythrocytes. This result indicates the possibility that hydroquinone specifically disturbed erythrocyte membranes. The large amount of erythrocytes we found in cell suspensions suggests that hydroquinone (or its metabolites) prevented erythrocyte haemolysis, which is an important step in the rinsing of lymphocyte pellets during the preparation of slides for the micronucleus assay. According to Denny (76) , this is very likely because benzoquinone did not cause haemolysis and instead protected erythrocytes from haemolytic stresses. As known, erythrocytes contain numerous proteins (77) . Having in mind that benzoquinone leads to adduct formation in haemoglobin and albumin (78, 79) , it is likely that interaction between benzoquinone and proteins prevent haemolysis. Similar effects of quinone and hydroquinone on proteins have been noted by other authors (80) (81) (82) . It is possible that such an effect of hydroquinone and its metabolites present in short-term lymphocyte cultures established from whole blood in some way leads to erythrocyte stabilization and their inability to remove from the cell pellet formed after centrifugation. However, these assumptions have to be further studied.
Conclusions and future perspectives This study is to a certain extent limited by the fact that it was accomplished on an in vitro model, which means that the results cannot be directly extrapolated to real in vivo conditions. Although the lymphocyte model is common in genetic toxicology testing and has been recently used in studies employing similar methods as ours (13, 14, 17) , the fact that human lymphocytes represent a population of resting cells that do not possess intrinsic metabolic activation suggests the need for further studies using other appropriate cell lines to unequivocally prove the obtained results. Lastly, we are aware that testing a much wider range of hydroquinone concentrations and using more sophisticated methods (e.g., specific modifications of the comet assay and more accurate methods for the detection of apoptosis) would provide a more accurate explanation of the observed effects, but at the moment this was not possible due to various technical and financial constraints.
When the results obtained by testing of hydroquinone in vitro are considered in their entirety, the genotoxic risk of exposure to its lowest concentration, which is far above the amount of hydroquinone produced by the metabolism following an uptake of the maximum daily allowable concentration of arbutin, is also relatively low. On the other hand, exposure to the two higher hydroquinone concentrations, which produced more detrimental effects in vitro, is not likely to be achieved in actual in vivo conditions. Taken together, in spite of all of the limitations, our findings should provide valuable information regarding hydroquinone toxicity and represent a solid base for our future investigations.
Istraživanje citotoksičnih, genotoksičnih i citogenetičkih učinaka hidrokinona na ljudskim limfocitima periferne krvi u uvjetima in vitro
Cilj ovog istraživanja bio je proučiti mehanizme toksičnosti hidrokinona i odnose između njegovih citotoksičnih, genotoksičnih i citogenetičkih učinaka na ljudskim limfocitima periferne krvi izloženima koncentracijama 8, 140 i 280 µg mL -1 tijekom 24 sata. Posljedice izlaganja testiranom spoju istražene su primjenom testa za otkrivanje stanica u apoptozi i nekrozi, komet-testa u alkalnim uvjetima i tzv. cytome inačice citohalazinom blokiranog mikronukleus-testa. Istražene koncentracije hidrokinona izazvale su relativno nisku citotoksičnost u limfocitima, koji većinom ugibaju apoptozom. Međutim, pri istim koncentracijama primjenom komet-testa uočene su značajne promjene u razinama primarnih oštećenja DNA u odnosu na kontrolu. Statistički značajno snižene vrijednosti svih parametara komet-testa u odnosu na kontrolne stanice upućuju na specifične mehanizme međudjelovanja hidrokinona i DNA. Dobiveni rezultati upućuju na mogućnost nastanka ukriženih veza u molekuli DNA (engl. cross-linking) i nastanak adukata u DNA nakon izloženosti dvjema višim koncentracijama hidrokinona, a povišene vrijednosti lomova u DNA, uočene nakon izlaganja najnižoj ispitanoj koncentraciji, upućuju na veći značaj oksidacijskih oštećenja i utjecaj mehanizama povezanih s inhibicijom enzima topoizomeraze II. Pri koncentraciji 8 µg mL -1 hidrokinon ne izaziva značajan porast broja mikronukleusa. Koncentracije 140 i 280 µg mL -1 potpuno koče diobu limfocita, a ujedno izazivaju i stabilizaciju membrana eritrocita, sprječavajući njihovu lizu. Dva dobivena rezultata značajan su doprinos postojećim saznanjima o toksičnosti hidrokinona: (I.) Ovo je prvo istraživanje u kojem je izmjereno smanjenje ukupne površine kometa limfocitne DNA nakon izlaganja hidrokinonu; (II.) Ovo je prvo istraživanje u kojem je primijenjena cytome inačica mikronukleus-testa, kojom smo dokazali da izloženost čak i vrlo niskim koncentracijama hidrokinona dovodi do značajno povišene učestalosti nastanka jezgrinih pupova u limfocitima. Uzevši u obzir ograničenja limfocita kao modela, ponajprije nedostatak unutarnje metaboličke aktivacije, za nedvojbenu potvrdu dobivenih rezultata predlažemo nastavak istraživanja i na drugim prikladnim modelima staničnih linija.
KLJUČNE RIJEČI: apoptoza; citohalazinom blokiran mikronukleus cytome test; jezgrini pupovi; primarna oštećenja DNA; ukupna površina kometa
